Lyra Therapeutics Dividends and Buybacks
Dividend criteria checks 0/6
Lyra Therapeutics does not have a record of paying a dividend.
Key information
n/a
Dividend yield
-226.8%
Buyback Yield
Total Shareholder Yield | -226.8% |
Future Dividend Yield | 0% |
Dividend Growth | n/a |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | n/a |
Payout ratio | n/a |
Recent dividend and buyback updates
No updates
Recent updates
Will Lyra Therapeutics (NASDAQ:LYRA) Spend Its Cash Wisely?
Jan 25We Think Lyra Therapeutics (NASDAQ:LYRA) Needs To Drive Business Growth Carefully
Sep 10Is Lyra Therapeutics (NASDAQ:LYRA) In A Good Position To Deliver On Growth Plans?
Mar 12Lyra Therapeutics appoints Nieman as Chief Medical Officer
Jul 05Lyra Therapeutics: Progress In The Clinic
May 18A First Look At Lyra Therapeutics
Apr 21Is Lyra Therapeutics (NASDAQ:LYRA) In A Good Position To Deliver On Growth Plans?
Mar 30Is Lyra Therapeutics (NASDAQ:LYRA) In A Good Position To Invest In Growth?
Dec 14We Think Lyra Therapeutics (NASDAQ:LYRA) Can Afford To Drive Business Growth
Aug 28We're Not Very Worried About Lyra Therapeutics' (NASDAQ:LYRA) Cash Burn Rate
May 04How Many Lyra Therapeutics, Inc. (NASDAQ:LYRA) Shares Do Institutions Own?
Mar 05Companies Like Lyra Therapeutics (NASDAQ:LYRA) Are In A Position To Invest In Growth
Jan 11Lyra Therapeutics down 19% underwhelming data from lead program
Dec 07Lyra Therapeutics: An Intriguing Risk/Reward Proposition Tackling Chronic Rhinosinusitis
Nov 24Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if LYRA's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if LYRA's dividend payments have been increasing.
Dividend Yield vs Market
Lyra Therapeutics Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (LYRA) | n/a |
Market Bottom 25% (US) | 1.4% |
Market Top 25% (US) | 4.2% |
Industry Average (Pharmaceuticals) | 2.4% |
Analyst forecast (LYRA) (up to 3 years) | 0% |
Notable Dividend: Unable to evaluate LYRA's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate LYRA's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate LYRA's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as LYRA has not reported any payouts.